Esomeprazole 20 mg
Sponsors
AstraZeneca, Heidelberg University, Vecta Ltd., Pfizer, HK inno.N Corporation
Conditions
Duodenal UlcerGERDGastric UlcerGastroesophageal RefluxGastroesophageal Reflux DiseaseHealthyHeartburnLumbago
Phase 1
Phase 2
Phase 3
Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
CompletedNCT00441727
Start: 2007-02-28End: 2008-08-31Updated: 2012-07-16
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
CompletedNCT00595517
Start: 2007-10-31End: 2009-09-30Updated: 2012-09-14
Phase 4
Esomeprazole and Gastric Emptying of Beer
CompletedNCT00472550
Start: 2006-01-31End: 2006-11-30Updated: 2007-05-11
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
CompletedNCT01397084
Start: 2011-08-31End: 2012-01-31Updated: 2013-02-21
Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
CompletedNCT02708355
Start: 2016-01-31End: 2016-04-30Updated: 2017-04-19